Among women with severe maternal outcomes, oxytocin was used in 86% of the women for the prevention of postpartum hemorrhage, whereas only 68% of the women with severe PPH received oxytocin as a treatment agent among other treatment regimens. Here, OXT is linked to hemorrhage.